Literature DB >> 33467079

Detection of SARS-CoV-2 and Other Infectious Agents in Lower Respiratory Tract Samples Belonging to Patients Admitted to Intensive Care Units of a Tertiary-Care Hospital, Located in an Epidemic Area, during the Italian Lockdown.

Adriana Calderaro1, Mirko Buttrini1, Sara Montecchini2, Giovanna Piccolo1, Monica Martinelli3, Maria Loretana Dell'Anna2, Alan Di Maio3, Maria Cristina Arcangeletti1, Clara Maccari1, Flora De Conto1, Carlo Chezzi1.   

Abstract

The aim of this study was the detection of infectious agents from lower respiratory tract (LRT) samples in order to describe their distribution in patients with severe acute respiratory failure and hospitalized in intensive care units (ICU) in an Italian tertiary-care hospital. LRT samples from 154 patients admitted to ICU from 27 February to 10 May 2020 were prospectively examined for respiratory viruses, including SARS-CoV-2, bacteria and/or fungi. SARS-CoV-2 was revealed in 90 patients (58.4%, 72 males, mean age 65 years). No significant difference was observed between SARS-CoV-2 positives and SARS-CoV-2 negatives with regard to sex, age and bacterial and/or fungal infections. Nonetheless, fungi were more frequently detected among SARS-CoV-2 positives (44/54, 81.4%, p = 0.0053). Candida albicans was the overall most frequently isolated agent, followed by Enterococcus faecalis among SARS-CoV-2 positives and Staphylococcus aureus among SARS-CoV-2 negatives. Overall mortality rate was 40.4%, accounting for 53 deaths: 37 among SARS-CoV-2 positives (mean age 69 years) and 16 among SARS-CoV-2 negatives (mean age 63 years). This study highlights the different patterns of infectious agents between the two patient categories: fungi were prevalently involved among SARS-CoV-2-positive patients and bacteria among the SARS-CoV-2-negative patients. The different therapies and the length of the ICU stay could have influenced these different patterns of infectious agents.

Entities:  

Keywords:  SARS-CoV-2; bacteria; diagnosis; fungi; molecular assays; pandemic; respiratory viruses

Year:  2021        PMID: 33467079      PMCID: PMC7830127          DOI: 10.3390/microorganisms9010185

Source DB:  PubMed          Journal:  Microorganisms        ISSN: 2076-2607


  16 in total

Review 1.  SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis.

Authors:  Chitra Mohinder Singh Singal; Paritosh Jaiswal; Pankaj Seth
Journal:  ACS Chem Neurosci       Date:  2020-06-18       Impact factor: 4.418

2.  Comparison of peptide nucleic acid fluorescence in situ hybridization assays with culture-based matrix-assisted laser desorption/ionization-time of flight mass spectrometry for the identification of bacteria and yeasts from blood cultures and cerebrospinal fluid cultures.

Authors:  A Calderaro; M Martinelli; F Motta; S Larini; M C Arcangeletti; M C Medici; C Chezzi; F De Conto
Journal:  Clin Microbiol Infect       Date:  2014-01-13       Impact factor: 8.067

Review 3.  SARS-CoV-2 and COVID-19: From the Bench to the Bedside.

Authors:  Stefano Romagnoli; Adriano Peris; A Raffaele De Gaudio; Pierangelo Geppetti
Journal:  Physiol Rev       Date:  2020-06-04       Impact factor: 37.312

4.  First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020.

Authors:  Gianfranco Spiteri; James Fielding; Michaela Diercke; Christine Campese; Vincent Enouf; Alexandre Gaymard; Antonino Bella; Paola Sognamiglio; Maria José Sierra Moros; Antonio Nicolau Riutort; Yulia V Demina; Romain Mahieu; Markku Broas; Malin Bengnér; Silke Buda; Julia Schilling; Laurent Filleul; Agnès Lepoutre; Christine Saura; Alexandra Mailles; Daniel Levy-Bruhl; Bruno Coignard; Sibylle Bernard-Stoecklin; Sylvie Behillil; Sylvie van der Werf; Martine Valette; Bruno Lina; Flavia Riccardo; Emanuele Nicastri; Inmaculada Casas; Amparo Larrauri; Magdalena Salom Castell; Francisco Pozo; Rinat A Maksyutov; Charlotte Martin; Marc Van Ranst; Nathalie Bossuyt; Lotta Siira; Jussi Sane; Karin Tegmark-Wisell; Maria Palmérus; Eeva K Broberg; Julien Beauté; Pernille Jorgensen; Nick Bundle; Dmitriy Pereyaslov; Cornelia Adlhoch; Jukka Pukkila; Richard Pebody; Sonja Olsen; Bruno Christian Ciancio
Journal:  Euro Surveill       Date:  2020-03

Review 5.  Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective.

Authors:  Yang Yang; Md Sahidul Islam; Jin Wang; Yuan Li; Xin Chen
Journal:  Int J Biol Sci       Date:  2020-03-15       Impact factor: 6.580

6.  Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.

Authors:  Xiuyuan Ou; Yan Liu; Xiaobo Lei; Pei Li; Dan Mi; Lili Ren; Li Guo; Ruixuan Guo; Ting Chen; Jiaxin Hu; Zichun Xiang; Zhixia Mu; Xing Chen; Jieyong Chen; Keping Hu; Qi Jin; Jianwei Wang; Zhaohui Qian
Journal:  Nat Commun       Date:  2020-03-27       Impact factor: 14.919

7.  Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak.

Authors:  Shi Zhao; Qianyin Lin; Jinjun Ran; Salihu S Musa; Guangpu Yang; Weiming Wang; Yijun Lou; Daozhou Gao; Lin Yang; Daihai He; Maggie H Wang
Journal:  Int J Infect Dis       Date:  2020-01-30       Impact factor: 3.623

8.  SARS-CoV-2 infection diagnosed only by cell culture isolation before the local outbreak in an Italian seven-week-old suckling baby.

Authors:  Adriana Calderaro; Maria Cristina Arcangeletti; Flora De Conto; Mirko Buttrini; Paolo Montagna; Sara Montecchini; Francesca Ferraglia; Federica Pinardi; Carlo Chezzi
Journal:  Int J Infect Dis       Date:  2020-05-14       Impact factor: 3.623

9.  Human respiratory viruses, including SARS-CoV-2, circulating in the winter season 2019-2020 in Parma, Northern Italy.

Authors:  Adriana Calderaro; Flora De Conto; Mirko Buttrini; Giovanna Piccolo; Sara Montecchini; Clara Maccari; Monica Martinelli; Alan Di Maio; Francesca Ferraglia; Federica Pinardi; Paolo Montagna; Maria Cristina Arcangeletti; Carlo Chezzi
Journal:  Int J Infect Dis       Date:  2020-10-02       Impact factor: 3.623

10.  Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020.

Authors:  Jantien A Backer; Don Klinkenberg; Jacco Wallinga
Journal:  Euro Surveill       Date:  2020-02
View more
  3 in total

1.  COVID-19-associated fungal infections in Iran: A systematic review.

Authors:  Tina Nazari; Fatemeh Sadeghi; Alireza Izadi; Setayesh Sameni; Shahram Mahmoudi
Journal:  PLoS One       Date:  2022-07-11       Impact factor: 3.752

2.  Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp.

Authors:  Elisa Viciani; Paolo Gaibani; Andrea Castagnetti; Andrea Liberatore; Michele Bartoletti; Pierluigi Viale; Tiziana Lazzarotto; Simone Ambretti; Russell Lewis; Monica Cricca
Journal:  Int J Infect Dis       Date:  2022-02-09       Impact factor: 12.074

Review 3.  Epidemiology of Systemic Mycoses in the COVID-19 Pandemic.

Authors:  María Guadalupe Frías-De-León; Rodolfo Pinto-Almazán; Rigoberto Hernández-Castro; Eduardo García-Salazar; Patricia Meza-Meneses; Carmen Rodríguez-Cerdeira; Roberto Arenas; Esther Conde-Cuevas; Gustavo Acosta-Altamirano; Erick Martínez-Herrera
Journal:  J Fungi (Basel)       Date:  2021-07-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.